Why the study?
There is little emphasis on the efficacy of catheter ablation for ventricular arrhythmia when using burden reduction rather than recurrence as a marker of success.
Does catheter ablation reduce ventricular arrhythmia burden in patients with structural heart disease?
Does catheter ablation reduce ventricular arrhythmia burden in patients with structural heart disease?
Catheter ablation for structural heart disease-related ventricular arrhythmias significantly reduces VA burden, suggesting that burden reduction is a more appropriate metric for procedural success than singular VA recurrence.
Answers are grounded in this paper and cite their sources.
May support ≥75% VA burden reduction as ablation success metric in structural heart disease; hypothesis-generating and needs randomized confirmation.
BACKGROUND AND OBJECTIVES: There is little emphasis on the efficacy of catheter ablation for ventricular arrhythmia (VA) when using VA burden reduction as a marker for success. We examined the efficacy of catheter ablation using VA burden, rather than VA recurrence as a marker of success, following catheter ablation of structural heart disease (SHD) related VA. METHODS: Catheter ablation of SHD related VA was performed at a single centre over 4-years. VA episodes and implantable cardioverter defibrillator (ICD) therapies were recorded over the 6-months before and after final ablation. Outcomes were reported in terms of burden reduction and compared to singular VA recurrence. RESULTS: Overall, 108 patients were included in the study. Mean age 64.2±13.9 years, 86% male, mean left ventricular ejection fraction (LVEF) 42±16%. Median VA episodes and ICD therapy were significantly reduced after ablation (VA before: 10 [interquartile range, IQR: 2-38] vs. VA after: 0 [IQR: 0-2], p<0.001; anti-tachycardia pacing [ATP] before: 16 (IQR: 1.5-57) vs. ATP after: 0 [IQR: 0-2], p<0.001; shocks before: 1 [IQR: 0-5] vs. shocks after: 0 [IQR: 0-0], p<0.001). Procedural success at 6-months was significantly higher when considering ≥75% reduction in VA burden, rather than a singular VA-free survival (83% vs. 67%, p=0.001). CONCLUSIONS: The vast majority (>80%) of patients achieve reduction in VA burden (≥75% reduction) after catheter ablation for VA. This data suggests that catheter ablation is highly therapeutic when procedure success is defined as reduction in VA, rather than using a single VA recurrence as a metric for failure.
No takes yet. Share an insight, caveat, or question.
Bennett et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: